wenxiao

used to treat atherosclerosis; consists of Hirudo , Pheretima , Radix Salviae Miltiorrhizae , Cortex Moutan, Radix Curcumae, and Rhizoma Pinelliae

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Atherosclerotic Plaque (Atheroma) 06/01/2012 - "These data suggested that high, mid, and low doses of Wenxiao II Decoction can inhibit the expression of MCP-1 and VCAM-1, which may prevent the formation of or stabilize atherosclerotic plaques. " 06/01/2014 - "High, medium, and low doses of Wenxiao Decoction can inhibit the expressions of IL-6, ICAM-1, and MCP-1, which may prevent and stabilize atherosclerotic plaques. "
2.	Atherosclerosis 06/01/2012 - "To observe the effects of different doses of wenxiao II decoction on the expression of monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) in an experimental model of atherosclerosis in rabbits and to explore the mechanism by which it alleviates atherosclerosis. " 06/01/2014 - "To observe the effects of different doses of Wenxiao Decoction on the expression of interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1), and monocyte chemoattractant protein-1 (MCP-1) in experimental atherosclerotic rabbits and to explore the mechanism by which it alleviates atherosclerosis. "

1.	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
2.	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
3.	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
4.	Interleukin-6 (Interleukin 6)